top of page

Solving the Problem

GMDx DNA Helix_edited.png

What Do We Do

Developed clinically validated algorithms to determine the health of a patient’s immune system.

How Do We Do It?

Use proprietary algorithms, an extensive IP portfolio, advanced analytics, AI and machine learning capabilities.

Predict cancer progression

Identify genomic and clinical data

Apply proprietary genomic algorithms

Predict response to therapies and treatments

Profile diseases using AI/ML algorithms

Optimize drug development through Genomic Data Services

GMDx analytics (31 granted patents)

The GMDx Breakthrough

Innate Immune Fitness (IIF) Test

GMDx DNA Helix_edited.png

The GMDx Innate Immune Fitness (IIF) Score is the most accurate test developed today for predicting how patients will respond to cancer immunotherapy treatments.

IIF significantly outperforms standard tests like TMB and PD-L1.

GMDx IIF

TMB

PD-L1

IIF: Innate Immune Fitness​, TMB: Tumor Mutation Burden​,

PD-L1: Cell-based Biomarker, NPV: Negative predictive value

Immune System Health

Determination and Use Cases

GMDx DNA Helix_edited.png
bottom of page